Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
about
Role of the F-box protein Skp2 in lymphomagenesisExpression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic miceThe B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomasMicromanagement of lymphomas.PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing.Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins.Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies.Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma.Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesisNeoplastic development in plasma cells.Molecular basis of mantle cell lymphoma.MYC levels govern hematopoietic tumor type and latency in transgenic miceBodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.Apoptotic signaling by c-MYC.ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.Complex oncogenic translocations with gene amplification are initiated by specific DNA breaks in lymphocytes.Generation and evaluation of an IPTG-regulated version of Vav-gene promoter for mouse transgenesisLymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase.Selective ablation of the YxxM motif of IL-7Ralpha suppresses lymphomagenesis but maintains lymphocyte development.A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
P2860
Q24603883-0AF59721-C315-4D86-8A31-04F490F8527CQ24682728-300CA987-C0FB-4C25-BC91-D0C03CA9B8B7Q33346593-872064EF-2274-488B-BF25-E3021DBF1E38Q33346596-24638D7C-695E-4F0E-9A65-D1F0BFE03D5BQ33767159-B875D3BC-91F4-4218-83CF-DBC00B95BAA2Q33895521-FDD53D96-C5BC-4641-A8AB-0BC5D1FAFAC0Q34170806-BF4183C5-3205-4421-8DE1-8C4E10C38FADQ34188715-0D278221-D7BA-43DE-A1DF-3BD6907B8026Q34725050-5EA4A7D9-7D7C-4911-B5C3-36E7AE9FA2C7Q34924231-5C21FAEB-9140-4601-A632-B470BE473BF4Q34974240-8B6C0E3D-626F-4E8A-A4E4-7E4329E606D8Q34998323-81FAA482-EDF7-4947-B5F3-9B6CD0F83900Q35170940-E066AD03-883D-4A0F-B6C9-A7AB803FB195Q35612063-ECB97AF2-6637-4D7A-A71C-21F6D968F921Q35848951-2AF1B292-EDD6-429C-93CA-A2701A25D460Q36085962-44E9938E-ED00-4CAE-8923-55E9520887DBQ36776853-777385EC-8B82-41CC-87FD-91131D7FD12CQ37310199-82378FBD-492C-46EB-BE71-6AF6B9598922Q38836849-2031F0D5-872E-4163-9EDA-0AE3C0FABB0FQ38864150-93CC0A94-5780-4021-8F2A-317C95F82BA3Q39106369-D6A12B72-E17C-4F69-8532-D009ABF83220Q42027945-6F008C7D-F8BD-4CA8-BCA3-0624A3AEDC4FQ47602968-6FD1D249-3E40-4B84-A238-B8813F636433Q52600195-F2B509D8-B19E-4FD9-B405-26D33F7FACB6Q53391603-C6A33C49-F310-4125-ADA3-41D69F83ACD3
P2860
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
description
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im September 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/09/20)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/09/20)
@nl
наукова стаття, опублікована у вересні 1999
@uk
مقالة علمية (نشرت في 20-9-1999)
@ar
name
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@ast
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@en
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@nl
type
label
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@ast
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@en
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@nl
prefLabel
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@ast
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@en
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@nl
P2860
P50
P356
P1433
P1476
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1202997
P407
P577
1999-09-01T00:00:00Z
P5875
P6179
1000366316